Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment. (Q46523906)
Jump to navigation
Jump to search
scientific article published in June 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment. |
scientific article published in June 2005 |
Statements
Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment (English)
Rocío Peña
Jose M Mostaza
Fernando Laguna
María F García-Iglesias
Manuel Taboada